- Profit after tax (consolidated)
- Rs (62.3) mn
- EPS
- Rs (0.42) -625.0%
- EPS a year earlier
- Rs 0.08
PSX Insurance
CSIL Crescent Star Insurance Limited
Latest results: FY2025 · Dec 2025 Q2 FY2026 · Apr – Jun 2026
FY2025 total income Rs 166.0 mn (-34.7%), profit Rs 17.3 mn (-62.2%).
Last close · 13 Nov 2026
Rs 5.91 ▲ 0.19 (+3.32%)
▲ 49.2% 1 year
- Market cap
- Rs 878.3 mn
- P/E
- —
- TTM to Jun 2026
- P/B
- 0.90×
- Quarter to Jun 2026
- Sector 0.90×
- Dividend yield
- 0.0%
- FY2025
- ROE
- 1.8%
- FY2025
- Sector 14.1% · lower
- EPS
- Rs -0.40
- TTM to Jun 2026
- Book value / share
- Rs 6.58
- Quarter to Jun 2026
Fundamentals
CSIL at a glance
Net premium earned · FY2025
Rs 97.8 mn
▼ 56.4% year on year
Profit attributable to shareholders · FY2025
Rs 17.3 mn
▼ 62.2% year on year
EPS – basic (Rs) · FY2025
Rs 0.13
▼ 62.2% year on year
Dividend per share (Rs) · FY2025
Rs 0.00
Investments · FY2025
Rs 1.0 bn
▲ 18.4% year on year
Return on equity (ROE) · FY2025
1.8%
-3.3 pts year on year
Price performance
CSIL returns
Close Rs 5.91
13 Nov 2026
| Period | Return | Rs | vs KSE-100 |
|---|---|---|---|
| MTD Month to date | +13.4% +6.6 pts vs KSE | +0.70 | +6.6 pts KSE +6.9% |
| 3M 3 months | −6.2% −5.0 pts vs KSE | −0.39 | −5.0 pts KSE −1.2% |
| 6M 6 months | +0.7% −5.5 pts vs KSE | +0.04 | −5.5 pts KSE +6.2% |
| YTD Year to date | −24.9% −27.1 pts vs KSE | −1.96 | −27.1 pts KSE +2.2% |
| 1Y 1 year | +49.2% +38.5 pts vs KSE | +1.95 | +38.5 pts KSE +10.7% |
| Long term | |||
| 3Y 3 years | +239.7% +50.3% a year +25.0 pts vs KSE | +4.17 | +25.0 pts KSE +214.7% |
| 5Y 5 years | +217.7% +26.0% a year −71.1 pts vs KSE | +4.05 | −71.1 pts KSE +288.8% |
Price return from the last close before each period; the fiscal year ends 31 December, so year to date is also fiscal year to date. Dividends are not included.
Crescent Star Insurance Limited in brief
Crescent Star Insurance Limited (CSIL) reported total income of Rs 166.0 mn for FY2025 (Jan – Dec 2025), down 34.7% from FY2024.
Profit attributable to shareholders was Rs 17.3 mn (EPS Rs 0.13), down 62.2%.
No cash dividend was declared for FY2025.
Return on equity was 1.8%.
Over the last five years total income grew at a compound 7.7% a year.
At Rs 5.91 (close on 13 Nov 2026) the shares trade at 0.90× book value.
Scorecard vs Insurance
29 companies- Growth
- Weak
- 8.3%
- Profitability
- Weak
- 1.8%
- Financial health
- Not applicable
- —
- Valuation
- Loss-making
- —
- Dividends
- Below average
- 0.0%
Ratings place the company in its sector: growth (3-year revenue growth), profitability (net margin; return on equity for banks, insurers and finance companies), financial health (debt to equity, industrial companies), valuation (P/E at today's price) and dividends (yield at today's price). Five dots = top fifth. Rated within the sector when at least four companies report the figure, otherwise against all PSX companies of the same type (marked vs PSX). Information, not investment advice.
Corporate
CSIL announcements & payouts
- Profit after tax (unconsolidated)
- Rs (81.8) mn
- EPS
- Rs (0.55) -787.5%
- EPS a year earlier
- Rs 0.08
- Profit after tax (consolidated)
- Rs (60.4) mn
- EPS
- Rs (0.41) -373.3%
- EPS a year earlier
- Rs 0.15
- Profit after tax (unconsolidated)
- Rs (50.9) mn
- EPS
- Rs (0.34) -326.7%
- EPS a year earlier
- Rs 0.15
Financial highlights
CSIL financial results
| Rs mn | FY2025 Jan – Dec 2025 | FY2024 * Jan – Dec 2024 | FY2023 Jan – Dec 2023 | FY2022 * Jan – Dec 2022 | FY2021 Jan – Dec 2021 | FY2020 Jan – Dec 2020 | FY2019 Jan – Dec 2019 | FY2018 Jan – Dec 2018 | FY2017 Jan – Dec 2017 | FY2016 Jan – Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net premium earned | 97.8 | 224.4 | 277.8 | 118.3 | 95.6 | 112.6 | 110.9 | 111.3 | 106.0 | 206.3 |
| Investment income (net) | 63.2 | 30.0 | 21.2 | 9.1 | 4.7 | 2.1 | 3.7 | 0.3 | 103.7 | 6.9 |
| Net claims & benefits | 3.2 | 18.6 | (150.4) | (4.8) | (10.5) | (7.9) | (14.0) | (15.9) | (38.2) | (56.0) |
| Profit before tax | 31.7 | 41.7 | 22.0 | (18.8) | 38.3 | 53.8 | 32.6 | (188.8) | (133.1) | (44.4) |
| Profit attributable to shareholders | 17.3 | 45.8 | 56.9 | 4.5 | 38.8 | 48.9 | 30.8 | (140.4) | (65.4) | (14.7) |
| EPS – basic (Rs) Rs | 0.13 | 0.34 | 0.43 | 0.03 | 0.29 | 0.37 | 0.23 | (1.08) | (0.64) | (0.15) |
| Dividend per share (Rs) Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 1,003.2 | 847.2 | 882.9 | 871.7 | 789.5 | 741.0 | 620.4 | 525.5 | 517.9 | 99.8 |
| Total assets | 1,232.3 | 1,121.4 | 1,240.8 | 1,202.7 | 1,189.5 | 1,136.4 | 1,077.9 | 1,044.2 | 1,146.7 | 1,110.5 |
| Total equity | 836.4 | 772.2 | 740.1 | 745.4 | 758.1 | 723.3 | 679.0 | 661.6 | 805.6 | 653.8 |
| Rs mn | TTM to Jun 2026 | Q2 FY2026 Apr – Jun 2026 | Q1 FY2026 Jan – Mar 2026 | Q4 FY2025 Oct – Dec 2025 | Q3 FY2025 Jul – Sep 2025 | Q2 FY2025 Apr – Jun 2025 | Q1 FY2025 Jan – Mar 2025 | Q4 FY2024 Oct – Dec 2024 | Q3 FY2024 Jul – Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Net premium earned | 81.6 | 15.7 | 19.1 | 25.1 | 21.8 | 19.7 | 31.3 | 31.9 | 48.7 |
| Investment income (net) | 43.8 | 15.4 | (26.6) | 52.8 | 2.2 | 15.1 | (1.8) | 1.7 | (3.7) |
| Net claims & benefits | (4.8) | (6.6) | (0.4) | 2.1 | 0.1 | (0.8) | 1.8 | 0.6 | 4.2 |
| Profit before tax | (50.4) | (17.1) | (43.3) | 17.9 | (7.9) | 4.1 | 17.5 | (49.3) | (25.5) |
| Profit attributable to shareholders | (59.1) | (20.8) | (39.5) | 9.0 | (7.9) | 3.9 | 12.2 | (46.1) | (19.3) |
| EPS – basic (Rs) Rs | (0.40) | (0.14) | (0.27) | 0.07 | (0.06) | 0.03 | 0.09 | (0.35) | (0.15) |
| Dividend per share (Rs) Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 971.1 | 971.1 | 922.3 | 1,003.2 | 923.7 | 882.9 | 876.9 | 847.2 | 874.7 |
| Total assets | 1,208.9 | 1,208.9 | 1,282.0 | 1,232.3 | 1,160.7 | 1,124.5 | 1,147.2 | 1,121.4 | 1,166.3 |
| Total equity | 841.8 | 841.8 | 873.7 | 836.4 | 820.0 | 787.1 | 792.2 | 772.2 | 805.8 |
Figures in Pakistani rupees as reported by the company; costs and cash outflows in brackets. Free cash flow and book value per share are calculated by Smart Money; TTM = the latest four quarters. Updated 17 Oct 2026.
CSIL charts
Valuation
CSIL valuation at today's price
- Price to earnings (P/E)
- —
- EPS Rs -0.40 (TTM to Jun 2026)
- Price to book (P/B)
- 0.90×
- Book value Rs 6.58 (Quarter to Jun 2026)
- Dividend yield
- 0.0%
- DPS Rs 0.00 (FY2025)
- Earnings yield
- -6.7%
- EPS ÷ price
At the closing price of Rs 5.91 on 13 Nov 2026. P/E and P/B are not shown when earnings or book value are negative.
Sector peers
CSIL vs Insurance companies
| Company | Market cap | P/E | P/B | Yield | ROE | 3-yr growth |
|---|---|---|---|---|---|---|
| CSIL | Rs 878.3 mn | — | 0.90× | 0.0% | 1.8% | 8.3% |
| IGIHL | Rs 34.1 bn | 4.5× | 0.47× | 3.3% | 7.8% | 26.1% |
| AICL | Rs 31.4 bn | 5.4× | 0.58× | 4.5% | 12.0% | 27.0% |
| EFUG | Rs 25.1 bn | 4.3× | 0.84× | 8.0% | 20.9% | 22.1% |
| TPLI | Rs 19.3 bn | 126.5× | 6.68× | 0.0% | 1.7% | 13.4% |
| EWIC | Rs 17.4 bn | 8.9× | 2.40× | 0.0% | 26.8% | 39.7% |
| EFUL | Rs 16.7 bn | 6.6× | 1.64× | 9.4% | 25.3% | 12.7% |
| JLICL | Rs 16.1 bn | 7.4× | 0.87× | 8.1% | 13.8% | 10.8% |
| JGICL | Rs 15.4 bn | 3.6× | 0.72× | 7.7% | 19.6% | 22.9% |
Analyses & signals 0
Win rate — · 0 closed signals · average return —
No analyses published for CSIL yet.
CSIL: frequently asked questions
What is CSIL's EPS?
Crescent Star Insurance Limited reported basic earnings per share of Rs 0.13 for FY2025 (Jan – Dec 2025). Over the trailing twelve months (TTM to Jun 2026) EPS was Rs -0.40.
Does CSIL pay dividends?
Crescent Star Insurance Limited did not declare a cash dividend for FY2025.
What was CSIL's total income and profit in FY2025?
Crescent Star Insurance Limited reported total income of Rs 166.0 mn and profit attributable to shareholders of Rs 17.3 mn for FY2025 (Jan – Dec 2025).
What is CSIL's book value per share?
Crescent Star Insurance Limited's book value per share was Rs 7.32 at the end of FY2025. The shares trade at 0.90× book value.
How has CSIL's share price performed?
CSIL's share price is down 24.9% year to date (KSE-100: +2.2%), up 49.2% over one year (KSE-100: +10.7%) and up 217.7% over five years (KSE-100: +288.8%), as of 13 Nov 2026. These are price returns; dividends are not included.
Information only, not investment advice.